Generics Stalwart Teva Has Turned A Corner In Its Specialty Medicines Business
Source: SeekingAlpha
2025-11-14 10:38:47 ET
Thesis
Teva Pharmaceutical Industries Limited ( TEVA ), founded in 1901 and based in Israel, has developed into one of the world’s leading generics drug companies. They rank closely with Sandoz ( SDZNY ), Viatris ( VTRS ) – formed in 2020 as a merger between Upjohn and Mylan – Sun Pharma, and Dr. Reddy’s ( RDY ), all of which have developed over several decades the capacity to leverage their size and manufacturing capabilities to claim a decent share of the market. These companies operate a kind of oligopoly in this niche space....
Read the full article on Seeking Alpha
For further details see:
Generics Stalwart Teva Has Turned A Corner In Its Specialty Medicines Business
Takeda Pharmaceutical Company Limited American Depositary Shares
NASDAQ: TAK
TAK Trading
0.17% G/L:
$17.85 Last:
1,296,138 Volume:
$17.92 Open:
TAK Latest News
March 02, 2026 02:00:00 am
Takeda and Protagonist Announce U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Rusfertide as a Potential First-in-Class Therapy for Polycythemia Vera
February 24, 2026 09:35:00 am
Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity
TAK Stock Data
$57,107,745,653
3,115,826,299
N/A
157
N/A
Pharmaceuticals
Healthcare
JP
Chuo-ku
